XML 121 R44.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders’ Equity (Details Narrative) - USD ($)
 9 Months Ended 12 Months Ended
May 23, 2025
May 22, 2025
Apr. 04, 2025
Mar. 21, 2025
Feb. 06, 2025
Oct. 01, 2024
Sep. 16, 2024
Jan. 04, 2024
Oct. 31, 2023
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 10, 2024
Dec. 31, 2023
Dec. 31, 2022
Jun. 23, 2025
Feb. 26, 2025
May 11, 2023
May 10, 2023
Equity, Class of Treasury Stock [Line Items]                                      
Reverse stock split               1 for 20                      
Common stock shares issued                   9,092,518   8,092,518   140,264,240          
Common stock shares outstanding                   9,092,518   8,092,518   140,264,240          
Common stock, shares authorized                           7,066,772          
Common stock under the Plan, for services, value                   $ 190,000                  
Stock based compensation expense                   $ 0 $ 0                
Common stock, shares authorized                   200,000,000   200,000,000              
Common stock, par value                   $ 0.02   $ 0.02              
Preferred stock, shares authorized                   47,000   47,000              
Preferred stock, shares Issued                   0   0              
Preferred stock, shares outstanding                   0   0              
Stockholders' Equity Note, Stock Split                 reverse stock split of 1 for 55                    
Purchase price per share           $ 3.00                          
Shares issued                   100,000             36,433    
Legal fees received                               $ 161,000 $ 29,000    
Stock based compensation, option grants           880,000                          
Proceeds from grants           $ 2,640,000                          
Fair value grants           $ 50,000                          
Selling, General and Administrative Expenses [Member]                                      
Equity, Class of Treasury Stock [Line Items]                                      
Stock based compensation expense                   $ 5,000   $ 19,000              
Impact Bio Medical Inc [Member]                                      
Equity, Class of Treasury Stock [Line Items]                                      
Common stock shares issued                     11,503,955     10,000,000       0 125,073,621
Common stock shares outstanding                     11,503,955     10,000,000       0 125,073,621
Number of shares sold     890,800 499,800                              
Number of shares sold, value     $ 845,000 $ 1,500,000                              
Common stock, shares authorized                                   3,877,282,251 4,000,000,000
Common stock, par value                                     $ 0.001
Preferred stock, shares authorized                                     100,000,000
Preferred stock, shares Issued                     60,496,041     60,496,041         0
Preferred stock, shares outstanding                     60,496,041     60,496,041         0
Impact Bio Medical Inc [Member] | IPO [Member]                                      
Equity, Class of Treasury Stock [Line Items]                                      
Number of shares sold 45,400 115,600                                  
Number of shares sold, value $ 24,000 $ 63,000                                  
DSS BioHealth Securities, Inc. [Member] | Series A Convertible Preferred Stock [Member]                                      
Equity, Class of Treasury Stock [Line Items]                                      
Common stock, shares authorized                 60,496,041                    
Impact BioMedical, Inc. [Member]                                      
Equity, Class of Treasury Stock [Line Items]                                      
Reverse stock split                 reverse stock split of 1 for 55                    
Common stock shares issued                           3,877,282,251 3,877,282,251        
Common stock shares outstanding                           3,877,282,251 3,877,282,251        
Common stock, shares authorized                           70,496,041 70,496,041        
Impact BioMedical, Inc. [Member] | IPO [Member]                                      
Equity, Class of Treasury Stock [Line Items]                                      
Common stock shares issued                     11,497,703                
Common stock shares outstanding                     11,497,703                
Initial public offering             1,500,000                        
Number of shares sold                     1,500,000                
Common stock, par value             $ 0.001                        
Purchase price per share             $ 3.00                        
Allowance and expenses                   3,726,000                  
Cost and expense                   $ 1,500,000                  
Stock descrption                   A final prospectus relating to this Offering was filed with the Commission on September 16, 2024. The shares of Common Stock were approved to list on the NYSE American under the symbol “IBO” and began trading there on September 16, 2024. IBO also issued warrants to the Representative and its affiliates (the “Representative’s Warrants”) warrants to purchase the number of shares of Common Stock in the aggregate equal to 5% of the Common Stock to be issued and sold in this offering (including any Shares of Common Stock sold upon exercise of the over-allotment option, if applicable). The Representative’s Warrants are exercisable for a price per share equal to 125% of the public offering price. The warrants are exercisable at any time, in whole or in part, commencing nine (9) months from the date of commencement of sales of the offering and ending on the third anniversary thereof.                  
Sale of stock number of shares issued in remaining                     9,997,703                
Equity Incentive Plan [Member]                                      
Equity, Class of Treasury Stock [Line Items]                                      
Common stock under the Plan, for services         1,000,000                            
Common stock under the Plan, for services, value         $ 870,000                            
Common Stock [Member]                                      
Equity, Class of Treasury Stock [Line Items]                                      
Common stock under the Plan, for services                                    
Common stock under the Plan, for services, value                                    
Common Stock [Member] | DSS BioHealth Securities, Inc. [Member] | Maximum [Member]                                      
Equity, Class of Treasury Stock [Line Items]                                      
Ownership percentage                 88.00%                    
Common Stock [Member] | DSS BioHealth Securities, Inc. [Member] | Minimum [Member]                                      
Equity, Class of Treasury Stock [Line Items]                                      
Ownership percentage                 12.00%                    
Common Stock [Member] | DSS BioHealth Securities, Inc. [Member]                                      
Equity, Class of Treasury Stock [Line Items]                                      
Common stock, shares authorized                 60,496,041                    
Securities Purchase Agreement [Member] | Common Stock [Member]                                      
Equity, Class of Treasury Stock [Line Items]                                      
Initial public offering                         820,597            
Number of value common stock                         $ 803,000            
Securities Purchase Agreement [Member] | Common Stock [Member] | Heng Fai Ambrose Chan [Member]                                      
Equity, Class of Treasury Stock [Line Items]                                      
Initial public offering                         205,149            
Number of value common stock                         $ 197,000